CVS vs DDT · P/E 16, rev $402.07B vs rev $6.48B
CVS Health Corp (CVS) versus Dillards Capital Trust I (DDT) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Dillards Capital Trust I (DDT) common stock listed on NYSE.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Latest reported DDT revenue for 2025-02-01 was $6.48B. Net income was $593.5M. Revenue was down 4.0% from 2024-02-03 to 2025-02-01. DDT currently screens at market cap $0.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. DDT currently screens at market cap $0.
Not investment advice. Open the CVS and DDT stock pages for the full models.
Not investment advice.